Table 2 Association between CTC presence and grade, previous treatment and sites of metastases
pNETs | p | Midgut NETs | p | |||
|---|---|---|---|---|---|---|
(n = 119) | (n = 121) | |||||
CTC = 0 | CTC ≥ 1 | CTC = 0 | CTC ≥ 1 | |||
Tumour grade (%) | 0.0193 | 0.0009 | ||||
G1 | 74 | 26 | 55 | 45 | ||
G2 | 63 | 37 | 45 | 55 | ||
G3 | 55 | 45 | 29 | 71 | ||
Previous treatment (n) | 0.134 | 0.1418 | ||||
Treatment naive | 23 | 12 | 19 | 11 | ||
On SSAs | 14 | 7 | 22 | 28 | ||
Previous anti-cancer treatments* | 39 | 23 | 16 | 23 | ||
Lung metastases ( n ) | 0.31 | 0.33 | ||||
Yes | 5 | 1 | 5 | 9 | ||
No | 71 | 42 | 54 | 53 | ||
Peritoneal metastases ( n ) | 0.12 | 0.80 | ||||
Yes | 13 | 3 | 31 | 34 | ||
No | 63 | 40 | 28 | 28 | ||
Bone metastases ( n ) | < 0.0001 | 0.003 | ||||
Yes | 7 | 20 | 10 | 26 | ||
No | 69 | 23 | 49 | 36 | ||
Lymph node metastases ( n ) | 0.1861 | 0.4162 | ||||
Yes | 40 | 28 | 45 | 51 | ||
No | 36 | 15 | 14 | 11 | ||
